- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07555002
Prospective User Study and Multicenter Validation of Multimodal Medical Imaging Large Models
August 4, 2026 updated by: Junyan Li, The Third Affiliated Hospital of Southern Medical University
Prospective User Study and Multicenter Validation of Multimodal Medical Imaging Large Models in the Diagnosis of Common Systemic Diseases
Following model development and locking, the fixed model is evaluated in prospectively collected CT cohorts from two centers.
The study is observational and does not affect clinical care.
A subset of cases is used in a randomized crossover reader study.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
After model locking, CT data are prospectively collected at two centers for observational validation without retraining or parameter adjustment.
Model outputs do not influence patient management.
A subset of eligible cases is selected for the randomized crossover reader study.
Study Type
Observational
Enrollment (Actual)
310
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510630
- The Third Affiliated Hospital of Southern Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Patients from multiple medical centers in China who underwent systemic CT imaging for various clinical indications, representing a broad range of common systemic diseases.
Description
Inclusion Criteria:
- Patients who underwent CT examinations for common systemic diseases.
- Imaging data must have confirmed clinical reference standards, expert consensus, or pathological diagnosis.
- Availability of complete DICOM format images with standard acquisition protocols.
Exclusion Criteria:
- Poor image quality (e.g., severe motion or metal artifacts) that precludes definitive diagnosis.
- Cases with incomplete clinical or pathological reference standards.
- Corrupted image files or duplicate cases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Validation Cohort
Prospective Observational Validation Cohorts CT data are prospectively collected at two centers after model locking and used for observational model validation.
A subset is included in the randomized crossover reader study.
|
Radiologists interpret the medical images independently without any assistance from the AI model to establish a baseline performance.
Radiologists interpret the same set of medical images with the assistance of the multimodal medical imaging large model to evaluate the improvement in diagnostic performance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Case-level Diagnostic Accuracy and Area Under the ROC Curve (AUC)
Time Frame: Up to 1 week per evaluation period
|
Evaluation of case-level diagnostic accuracy (defined as the proportion of diagnostic decisions matching the clinical ground-truth label) and discrimination performance (measured by AUC) to compare unaided radiologist performance versus AI-assisted performance.
|
Up to 1 week per evaluation period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic Efficiency (Reading and Reporting Time)
Time Frame: Up to 1 week per evaluation period
|
Measurement of diagnostic efficiency recorded as the time (in seconds) taken by radiologists to complete the case review and generate findings, with and without AI assistance.
|
Up to 1 week per evaluation period
|
|
Inter-rater Agreement (Fleiss' Kappa)
Time Frame: Up to 1 week per evaluation period
|
Assessment of diagnostic consensus and inter-rater consistency among participating radiologists measured using Fleiss' kappa (κ).
|
Up to 1 week per evaluation period
|
|
Clinical Report Quality and Semantic Accuracy Score
Time Frame: Up to 1 week per evaluation period
|
Assessment of AI-generated draft report quality evaluated by senior experts on a 5-point Likert scale (focusing on semantic accuracy and clinical relevance) and automated metrics (GREEN and ROUGE-L).
|
Up to 1 week per evaluation period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yinghua Zhao, PhD, The Third Affiliated Hospital of Southern Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2026
Primary Completion (Actual)
June 8, 2026
Study Completion (Actual)
July 10, 2026
Study Registration Dates
First Submitted
April 21, 2026
First Submitted That Met QC Criteria
April 21, 2026
First Posted (Actual)
April 28, 2026
Study Record Updates
Last Update Posted (Actual)
August 7, 2026
Last Update Submitted That Met QC Criteria
August 4, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 2025-ER-141
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
To protect patient privacy and comply with institutional data security regulations.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.